The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.

There is no alteration in prognosis or cancer progression following HCC development after HCV treatment. However, baseline nonmalignant liver lesions, diabetes and thrombocytopaenia increase the risk of HCC, and HCC is associated with a decreased SVR rate.